This metabolite features a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% from the parent drug. Plasma concentrations of the metabolite are about 40% of These seen for sildenafil, so that the metabolite accounts for about 20% of sildenafil’s ph